Literature DB >> 13481247

Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.

F M DAVENPORT, A V HENNESSY.   

Abstract

The antibody orienting effects of prior infections with antigenic variants of influenza viruses were confirmed by studies with monovalent adjuvant vaccines and with polyvalent aqueous and adjuvant preparations. In either case, the predominant antibody response was of a "booster" type, directed against the major antigens of strains of original infection. It was shown that vaccination with appropriate strains, selected as antigenic prototypes, could orient or predetermine subsequent antibody response upon revaccination. Moreover, the effects of exposure by vaccination were found to be durable and to constitute a foundation upon which future antibody dividends could be accumulated. As a result, it seems feasible to induce by vaccination a more lasting broad composite antibody protection against influenza if appropriate preparations and schedules are used.

Entities:  

Keywords:  INFLUENZA/immunology

Mesh:

Substances:

Year:  1957        PMID: 13481247      PMCID: PMC2136834          DOI: 10.1084/jem.106.6.835

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Studies of antibodies to strains of influenza virus in persons of different ages in sera collected in a postepidemic period.

Authors:  A V HENNESSY; F M DAVENPORT; T FRANCIS
Journal:  J Immunol       Date:  1955-11       Impact factor: 5.422

2.  Viruses: the versatile parasites; the arthropod-borne group of animal viruses.

Authors:  J CASALS
Journal:  Trans N Y Acad Sci       Date:  1957-01

3.  New antigenic variant in Far East influenza epidemic, 1957.

Authors:  H M MEYER; M R HILLEMAN; M L MIESSE; I P CRAWFORD; A S BANKHEAD
Journal:  Proc Soc Exp Biol Med       Date:  1957-07

4.  Influenza vaccination in a residential boys' school; report to the medical research council committee on clinical trials of influenza vaccine.

Authors:  L A HATCH; G F HAWKINS; J C MCDONALD
Journal:  Br Med J       Date:  1956-11-24

5.  Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine.

Authors:  M R HILLEMAN; R A STALLONES; R L GAULD; M S WARFIELD; S A ANDERSON
Journal:  Proc Soc Exp Biol Med       Date:  1956-06

6.  A serological recapitulation of human infection with different strains of influenza virus.

Authors:  T FRANCIS; F M DAVENPORT; A V HENNESSY
Journal:  Trans Assoc Am Physicians       Date:  1953

7.  Influenza: the new acquayantance.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

8.  The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion.

Authors:  J E SALK; M L BAILEY; A M LAURENT
Journal:  Am J Hyg       Date:  1952-05

9.  The antigenic composition of influenza virus measured by antibody-absorption.

Authors:  K E JENSEN; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

10.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  26 in total

1.  STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).

Authors:  V VONKA; M TARABCAK; Z JANDA
Journal:  Arch Gesamte Virusforsch       Date:  1964

2.  Hemagglutinin inhibition with ether-treated antigen as a more sensitive method to measure the immunological response to an Asian influenza virus vaccine.

Authors:  G H WERNER; R SHARMA; L GOGOLSKI
Journal:  Arch Gesamte Virusforsch       Date:  1960

3.  Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.

Authors:  A V HENNESSY; F M DAVENPORT
Journal:  Public Health Rep       Date:  1961-05       Impact factor: 2.792

4.  [Role of the Commission on Influenza].

Authors:  F M DAVENPORT
Journal:  Public Health Rep       Date:  1958-02       Impact factor: 2.792

Review 5.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

6.  Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.

Authors:  Yoon Seok Choi; Yun Hee Baek; Wonseok Kang; Seung Joo Nam; Jino Lee; Sooseong You; Dong-Yeop Chang; Jong-Chan Youn; Young Ki Choi; Eui-Cheol Shin
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

7.  Spread of influenza.

Authors: 
Journal:  Br Med J       Date:  1967-10-14

Review 8.  A vaccine for HIV type 1: the antibody perspective.

Authors:  D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

9.  Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha.

Authors:  D A Tyrrell; M Peto; N King
Journal:  J Hyg (Lond)       Date:  1967-09

10.  Antibody responses after repeated influenza A virus immunizations among schoolchildren in Japan.

Authors:  N Yamane; M Hiratsuka; J Arikawa; T Odagiri; N Ishida
Journal:  J Hyg (Lond)       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.